In a filing, Stoke Therapeutics Inc revealed its Director EDWARD M KAYE acquired Company’s shares for reported $1.22 million on Aug 29 ’25. In the deal valued at $19.77 per share,61,885 shares were bought.
Then, JONATHAN ALLAN bought 22,117 shares, generating $437,253 in total proceeds.
Before that, Ticho Barry sold 2,805 shares. Stoke Therapeutics Inc shares valued at $51,158 were divested by the CHIEF MEDICAL OFFICER at a price of $18.24 per share. As a result of the transaction, Ticho Barry now holds 23,970 shares, worth roughly $0.47 million.
Jefferies initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on July 18, 2025; the price target was $30. A number of analysts have revised their coverage, including Chardan Capital Markets’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. TD Cowen revised its rating on March 26, 2024. It rated STOK as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of STOK
On Friday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock fall -0.05% to $19.76. Over the last five days, the stock has gained 1.02%. Stoke Therapeutics Inc shares have risen nearly 42.47% since the year began. Nevertheless, the stocks have risen 79.15% over the past one year. While a 52-week high of $19.97 was reached on 08/29/25, a 52-week low of $5.35 was recorded on 04/09/25.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 19.41, which if violated will result in even more drops to 19.07. On the upside, there is a resistance level at 20.05. A further resistance level may holdings at 20.35.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2025-08-15, dropping by -0.31 million shares to a total of 11.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 11.5 million shares. There was a decline of -2.73%, which implies that there is a negative sentiment for the stock.
